Golden State Medical Supply, Inc. has voluntarily recalled 1 lot of Clopidogrel 75mg Tablets and 1 lot of Atenolol 25mg Tablets due to a report stating that a bottle containing Clopidogrel 75mg Tablets was mislabeled as Atenolol 25mg Tablets.

Atenolol is indicated for the treatment of hypertension. Clopidogrel is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with acute coronary syndrome and in patients with established peripheral arterial disease or with a history of recent MI or stroke. 

The following products, which were primarily sold to AmerisourceBergen and McKesson, are being recalled out of an abundance of caution:

  • Clopidogrel 75mg Tablets, 1000-count bottle; GSMS NDC 51407-032-10; Lot # GS046745; Expiration Date 12/2023
  • Atenolol 25mg Tablets, 1000-count bottle; GSMS NDC 60429-027-10; Lot # GS046745; Expiration Date 12/2023
To date, the Company has not received any reports of adverse events related to this recall. Credit: FDA.

To date, the Company has not received any reports of adverse events related to this recall.

Adverse reactions or quality problems should be reported to the Food and Drug Administration’s MedWatch program.

Reference

Golden State Medical Supply, Inc. issues a voluntary nationwide recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets due to a label mix-up. News release. Golden State Medical Supply, Inc. Accessed September 30, 2022. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/golden-state-medical-supply-inc-issues-voluntary-nationwide-recall-atenolol-25-mg-tablets-and